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Abstract
Human cytomegalovirus (HCMV) is the leading cause of congenital viral infection in the United
States and Europe. Despite the significant morbidity associated with prenatal HCMV infection, little
is known about how the virus infects the fetus during pregnancy. To date, primary human
cytotrophoblasts (CTBs) have been utilized to study placental HCMV infection and replication;
however, the minimal mitotic potential of these cells restricts experimentation to a few days, which
may be problematic for mechanistic studies of the slow-replicating virus. The aim of this study was
to determine whether the human first trimester CTB cell line SGHPL-4 was permissive for HCMV
infection and therefore could overcome such limitations. HCMV immediate early (IE) protein
expression was detected as early as 3 hours post-infection in SGHPL-4 cells and progressively
increased as a function of time. HCMV growth assays revealed the presence of infectious virus in
both cell lysates and culture supernatants, indicating that viral replication and the release of progeny
virus occurred. Compared to human fibroblasts, viral replication was delayed in CTBs, consistent
with previous studies reporting delayed viral kinetics in HCMV-infected primary CTBs. These
results indicate that SGHPL-4 cells are fully permissive for the complete HCMV replicative cycle.
Our findings suggest that these cells may serve as useful tools for future mechanistic studies of
HCMV pathogenesis during early pregnancy.
Findings
Human cytomegalovirus (HCMV) is a ubiquitous beta-
herpesvirus that is the leading cause of congenital viral
infection in the United States and Europe. Intrauterine
transmission of the virus occurs in approximately 40% of
pregnant women with primary HCMV infection, and the
incidence of congenital HCMV infection is an estimated
1% of newborns [1-3]. Although the pathogenesis of
HCMV transmission to the fetus during pregnancy is
unclear, the placenta has been implicated as an important
determining factor [4-8]. Primary first trimester extravil-
lous cytotrophoblasts (CTBs), which are specialized pla-
cental epithelial cells that invade and remodel the uterine
wall during placentation, have been previously shown to
be fully permissive for HCMV infection in vitro [7,9].
Additionally, using an in vitro coculture system, Maidji
and colleagues demonstrated that infected uterine micro-
vascular endothelial cells transmit HCMV to differentiat-
ing invading CTBs, suggesting that placental HCMV
infection can occur in a retrograde fashion that initiates in
the maternal endothelium [8]. Despite these reports, the
minimal mitotic potential of primary CTBs restricts exper-
imentation to a few days, which may be problematic for
Published: 17 November 2004
Virology Journal 2004, 1:8 doi:10.1186/1743-422X-1-8
Received: 02 September 2004
Accepted: 17 November 2004
This article is available from: http://www.virologyj.com/content/1/1/8
© 2004 LaMarca et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Virology Journal 2004, 1:8 http://www.virologyj.com/content/1/1/8
Page 2 of 4
(page number not for citation purposes)
Productive HCMV infection in SGHPL-4 and HFF cells Figure 1
Productive HCMV infection in SGHPL-4 and HFF cells. (A-E) HCMV IE protein expression in human cytotrophoblasts. 
SGHPL-4 () or HFF (■ ) cells were infected with HCMV strain RVdlMwt-GFP [17] at a MOI of 2.5 PFU per cell and incubated 
at 37°C for 1, 4, 8, 12, 24, 48, 72, 96,120 or 144 h. At the indicated times, cells were fixed and stained for HCMV IE 1/2 and 
DAPI (Molecular Probes) and visualized on a Zeiss Axio Plan II microscope (Thornwood, NY). To determine the number of 
HCMV-infected cells, three fields of view were considered and the percent of IE-positive cells was calculated as: (average 
number of IE-stained cells/average number of DAPI-stained cells) × 100. The graph demonstrates an increase in the percentage 
of SGHPL-4 and HFF cells expressing IE 1/2 over a period of time. Representative images of HCMV IE 1/2 are depicted at 8 h 
p.i in (B) CTBs and (C) HFFs and at 120 h p.i. in (D) CTBs and (E) HFFs; IE 1/2-red, DAPI-blue, overlaid-purple. (F) Infected 
CTBs produce and release infectious virions. SGHPL-4 or HFF cells were inoculated with HCMV at a MOI of 0.1 PFU per cell. 
At the indicated times, cells or culture medium were harvested, freeze-thawed three times, and titers of infectious virus in 
SGHPL-4 cell lysates (❍ ) and supernatants () and HFF cell lysates (● ) and supernatants (▲ ) were determined by a microtiter 
plaque assay on HFFs [18]. Infectious progeny virus was detected in both cell lysates and culture supernatants of SGHPL-4 and 
HFF cells. The dashed line represents the lower limit of detection of the plaque assay used to measure viral titers.
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mechanistic studies of the slow-replicating virus.
Alternatively, the utilization of trophoblast cell lines
would provide an easily manipulative in vitro model for
the study of HCMV infection of the placenta. In the
present study, we used a first trimester human extravillous
CTB cell line, termed SGHPL-4, to investigate HCMV rep-
lication. SGHPL-4 cells were derived from first trimester
chorionic villous tissue and have been described previ-
ously. Importantly, these cells share many characteristics
with isolated primary cells, including the expression of
cytokeratin-7, HLA class I antigen, HLA-G, BC-1, CD9,
human chorionic gonadotrophin, and human placental
lactogen[10-12].
The lytic replication cycle of HCMV is a temporally regu-
lated cascade of events that is initiated when the virus
binds to host cell receptors. Upon entry into the cell, the
viral DNA translocates to the nucleus where viral gene
expression occurs in a stepwise fashion beginning with
the expression of immediate early (IE) genes (reviewed in
[13]). To initiate studies of HCMV infection in the
SGHPL-4 cell line, placental CTBs and human foreskin
fibroblasts (HFFs) were infected with HCMV and the
nuclear HCMV IE proteins (IE 1/2; Chemicon, Temecula,
CA) were examined by immunofluorescence at various
intervals after viral infection. At 3 h p.i., IE 1/2 was present
in SGHPL-4 cells in similar numbers to that of HFFs. In
fact, the percentages of IE-positive cells initially did not
differ between CTBs and HFFs, suggesting that viral entry
into the cells and IE transcription occurred at similar rates
between the cell types (Figure 1A,1B,1C). Characteristic
cytopathic effects of HCMV infection including swollen
cells with nuclear inclusions were observed in both
SGHPL-4 and HFF cells by 48 h p.i. (data not shown), and
throughout a 6 day culture period, the numbers of IE-pos-
itive cells increased continuously in both cell types (Figure
1A). Interestingly, the rate of IE 1/2 protein expression in
SGHPL-4 cells as compared to HFFs appeared to differ
beginning at 72 h p.i. By 72 h p.i., there was a 40%
increase in the percentage of IE-positive HFFs over
SGHPL-4 cells. While nearly 100% of HFFs stained posi-
tive for IE 1/2 120 h (5 days) p.i., the maximum fraction
of IE-positive SGHPL-4 cells did not exceed 60% (Figure
1A,1D,1E), suggesting that subsequent viral gene expres-
sion and thus cell-to-cell viral spread may be kinetically
delayed. These findings are consistent with other reports
demonstrating delayed kinetics of viral gene expression in
primary CTBs as compared to primary fibroblasts [14].
Although several studies have shown that first trimester
primary trophoblasts can be permissively infected with
HCMV, some reports have demonstrated that progression
through the replicative cycle was slow and progeny virus
remained predominantly cell associated [9,15,16]. To
determine whether SGHPL-4 cells support productive
HCMV replication, 9 day viral growth assays were
performed (Figure 1F). SGHPL-4 and HFF cells were inoc-
ulated with HCMV at a MOI of 0.1 PFU per cell, and both
culture lysates and supernatants were titered for infectious
virus at various days p.i. While viral titers in infected HFFs
were detectable as early as 2 days p.i., viral replication was
undetectable or below the lower limit of detection of the
assay in SGHPL-4 lysates up to 3 days p.i. However, at
days 5–9 p.i., HCMV replicated to titers of ≥ 5000 and
3600 PFU/ml in SGHPL-4 cell lysates and supernatants,
respectively. Relative to HFF-infected control cultures,
viral titers recovered from SGHPL-4 culture lysates and
supernatants were reduced by ~20- and ~200-fold, respec-
tively (Figure 1F). While viral titers were decreased in
infected SGHPL-4 cells as compared to infected HFFs, pla-
cental CTBs effectively supported productive viral replica-
tion as measured by infectious intracellular and
extracellular virions. Moreover, when SGHPL-4 cells were
infected with another laboratory-derived strain of HCMV
(strain AD169), similar results were obtained (data not
shown) suggesting that viral replication was not virus-
strain specific. Collectively, these data indicate that
SGHPL-4 cells support productive HCMV replication.
In the present study, we demonstrate that the first trimes-
ter extravillous CTB cell line SGHPL-4 is fully permissive
for HCMV replication. The utilization of a CTB cell line,
rather than primary CTBs and explant cultures that are
short-lived cultures, may provide an experimental advan-
tage for in vitro studies of placental HCMV infection. We
propose that the permissiveness for HCMV replication in
SGHPL-4 cells may allow for future studies in elucidating
the molecular mechanism(s) of HCMV infection and
pathogenesis at the maternal-fetal interface during early
pregnancy.
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